Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD (AURORA)

This study has been completed.
Beijing DMS Pharma Ltd.
The Digital Angiography Reading Center (DARC)
Information provided by (Responsible Party):
Chengdu Kanghong Biotech Co.,Ltd. Identifier:
First received: July 6, 2010
Last updated: November 5, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)